RAAS Flashcards

(49 cards)

1
Q

RAAS

A

Angiotensin II and aldosterone regulate fluid and BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Renin

A

Produced in the kidney, release can be triggered by multiple factors:
Decrease in BP
Decrease in blood volume
Decrease in plasma sodium content
Decrease in renal perfusion
Renin causes formation of angiotensin I from angiotensin (secreted by liver)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Angiotensin system

A
Angiotensin I (inactive) has weak activity in the body, and precursor to II
Kinase II (found in blood) converts angiotensin I to II
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Angiotensin II

A

Vasoconstriction (more effect on arteries)
Stops nitric oxide to stop vasodilation
Stimulation of aldosterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Angiotensin II indirect actions

A

Sympathetic neurons to promote NE release
Adrenal medulla to promote Epi release
On adrenal cortex to promote secretion of aldosterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Aldosterone

A

Aldosterone acts on distal tubules in the kidney to cause sodium retention, and excretion of K+ and H+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

4 main drug families affect RAAS

A

ACE inhibitors
ARBs (angiotensin II receptor blockers)
Direct renin inhibitors (DRIs)
Aldosterone antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ACE inhibitors

A

Stop conversion of angiotensin I to II

Adverse effects include cough, angioedema, first dose hypotension, and hyperkalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

More ACE inhibitors sides

A

10% get dry, persistent cough
Stopping can cause potassium retention in kidney
HyperK+ rare, but pts shouldn’t be taking K+ supp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ACE inhibitor MAO

A

Reduce level of angiotensin II
Increase levels of bradykinin (inhibits kinase II)
End result is non constricted blood vessels and stop release of aldosterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ace inhibitor name

A
Pril
Benazepril
Captopril
Enalapril
Lisinopril
Ramipril
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ARBs

A

Block actions of angiotensin II
Lower risk of cough and hyperk+
Usually secondary to ace inhibitors which have better success in decreased cardiac morbidity and mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ARBs

A

Block angiotensin II, also block release of aldosterone and so Na+ and H2O excretion is increased

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ARBs names

A
Sartan
Losartan
Valsartan
Olmesartan
Eprosartan
Candesartan
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DRIs

A

Direct Renin inhibitors
Act on renin to inhibit conversion of angiotensin to angiotensin I
Aliskiren is the only one, used for HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Aldosterone antagonists

A

Block receptors for aldosterone for HTN and heart failure

2 drugs - eplerenone and spironolactone - K+ sparing diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Aldosterone receptors

A

In the kidney, activation of aldosterone receptors promotes excretion of K and retention of Na+ and H2O
Receptor blockade has opposite effect, retention of K+ and excretion of Na+ and H2O

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

ACE inhibitors used in

A

HTN, CHF, diabetic neuropathy, MI and prevention of cardiovascular risks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

ARBS indications

A

HTN, CHF, diabetic neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Aldosterone agonist indications

A

HTN, CHF also hypokalemia and hyperaldosteronism

21
Q

DRIs

A

Direct renin inhibitors, for HTN

22
Q

Angiotensions

A

I II and III
I is a precursor to II and isn’t very active
II is very active
III is from degradation of II and is moderately active

23
Q

Angiotensin II vasoconstriction

A

Direct vascular smooth muscle activation (more arterial than veins because of this) and also causes release of norepi, promotes medulla to release epi and CNS to increase sympa outflow to vessels

24
Q

Aldosterone

A

Released from angio II below vasoconstriction threshold.
From low Na+ or high K_
Acts on DISTAL tubules to retain sodium and excrete K+ and H+

25
Angio II formed through
Renin, ACE
26
Renin
Catalyzes angio I from angiotensin It is the rate limiting step in I and II formation (II needs I) Produced by juxtaglomerular cells of kindey
27
Renin is released from
Drop in BP, volume, Na+ or renal perfusion
28
ACE (kinase II)
Converts I to II On luminal surface of all blood vessels, lungs are especially rich Called Kinase II when acting on bradykinin
29
Angio II promoting renal water retention
Takes days weeks or even months | Constricts renal vessels to reduce GFR and stimulates release of aldosterone
30
ACE inhibitors adverse effects
Cough, angioedema, first dose hypotension and hyperkalemia
31
Kinase II (ACE) effects
If ACE is blocked, angio II goes down but bradykinin goes up (can't be converted to inactive) Vasodilation (secondary to increase prostaglandins and nitric oxide), cough and rarely angio edema occur
32
Effects of decreasing ACE (ace inhibitors)
Vasodilation, decreased volume and cardiac remodeling, potassium retention, fetal injury
33
ACE inhibitors suffix
PRIL
34
ACE inhibitors renal failure
Renally excreted, therefore need reduced dose for renal failure pts
35
Non BP effects on angio II
Increased migration, proliferation and hypertrophy of vasc smooth muscle cells Increased ECM in VSM cells Hypertrophy of cardiac myocytes Increased ECG matrix by cardiac fibroblasts (this means it contributes to atherosclerosis and blocking lowers risk of MI and stroke)
36
ACE inhibitors in heart failure
Lower arterial tone to improve blood flow Reduce afterload to increase CO Venos dilation improves pulmonary congestion and edema Dilate kidney vessels to improve flow Excrete Na+ and volume which reduces edema and preload (drops right sided strain)
37
ACE inhibitors for post MI pts
Captopril, lisinopril, trandolapril
38
ACE inhibitors kidneys
Reduce glomerular filtration pressure to prevent damage. When renal efferent arterial pressure is increased it increases back pressure in glomerulus Slows progression of established nephropathy but does not protect against kidney damage
39
Coversyl
Ace inhibitor, perindopril
40
ACE in renal failures
If renal stenosis is present, angio II is good as it maintains renal perfusion
41
ACE inhibitors interactions
Can cause lithium to accumulate | NSAIDS reduce antihypertensive effects
42
Indapamide
Thiazide like diuretic. Incombo with coversyl called coversyl plus
43
Rampiril
On its on. Altace is combine with HCT (hydrochlorothiazide)
44
ARBS vs ACE inhibs
Biggest difference is no hyperK+ or cough with ARBS | ARBS aren't proven to lower odds of MI/STROKE as well as ACE inhibitors
45
ARBS suffix
Sartans | ARBS are reserved for pts who can't tolerate ACE inhibs as mortality benefits aren't proven with ARBS
46
Angioedema
More common in ACE inhibitors but both may cause it and is an absolute contraindication
47
MOA aliskiren a DRI
Binds to renin tightly and inhibits its ability to clean angio into angio I and therefore reduces both angio II and aldosterone Only approved for HTN
48
Aldosterone antagonists are
Spironolactone and eplerenone. Spironolactone is less selective
49
MOA Aldosterone antagonists
``` Blocks aldosterone (selectively so no effect on glucocorticoids, progresterone, androgens) blocking aldosterone and so increases K+ and decreases Na+ Metabolized by CYP3A4 and inhibtors of 3A4 have a very strong effect on drug concentration ```